Research Article| Volume 46, ISSUE 8, P703-706, December 1993

Botulinum A chemodenervation: a new modality in cerebral palsied hands

      This paper is only available as a PDF. To read, Please Download here.


      Botulinum A chemodenervation of the Adductor Pollicis muscle for the treatment of the thumb-in-palm deformity in cerebral palsied hands is presented as a new therapeutic option.
      Early results of a clinical trial in five hemiparetic Cerebral Palsied (C.P.) children are assessed using a prospective nontrialist-biased study design based on an independent panel assessment of pre- and post-intervention photographic and videotaped records of hand function and appearance, in combination with grip dynamometry and goniometry.
      All cases are shown to improve in terms of both function and appearance with results approaching statistical significance (p = 0.06) when assessed by the Wilcoxon's matched-pairs signed rank test, despite the small study group.
      The modality is shown to be simple, safe and effective over the period reported (229 days). The benefit is sustained beyond the period of muscle paresis and ongoing long term follow-up will document the need for, and timing of, reinjection.


        • Chait LA
        • Kaplan I
        • Stewart-Lord B
        • Goodman M
        Early surgical correction in the cerebral palsied hand.
        J Hand Surg. 1980; 5: 122-126
        • Alpar J
        Botulinum toxin and its uses in the treatment of ocular disorders.
        American Journal of Optometry and Physiological Optics. 1987; 64: 79-82
        • Goldspink G
        • Tabary C
        • Tabary JC
        • Tardieu C
        • Tardieu G
        Effect of denervation on the adaptation of sarcomere number and muscle extensibility to the functional length of the muscle.
        J Physiol. 1974; 236: 733-742
        • Scott AB
        Chemical alterations of eye muscle function.
        (Frank D)in: Costenbader Lecture, 14th annual meeting of the American Academy of Paediatrics for Ophthalmology and Strabismus, BostonMay 1988
        • Scott AB
        • Kraft SP
        Botulinum toxin in the management of lateral rectus paresis.
        Ophthalmology. 1985; 92: 676-683
        • Eustis HS
        • Ellis GS
        Botulinum toxin.
        Ophthalmology Clinics of North America. 1989; 2: 163
        • Dunlop D
        • Pittar G
        • Dunlop C
        Botulinum toxin in ophthalmology.
        Aust N Z J Ophthalmol. 1988; 16: 15-20
        • Stewart-Lord BM
        Assessment and splintage of the hand in cerebral palsy.
        in: Proceedings of the World Federation of Occupational Therapists, 6th International Congress, VancouverAugust 1974